ArticleFrontiers in rehabilitation sciences2026
Robot-assisted gait training yields superior functional gains in non-ambulatory subacute stroke patients.
Article in Frontiers in rehabilitation sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04910217 (Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: A randomized controlled trial (NCT04910217) demonstrated that the addition of robot-assisted gait training (RAGT) using the Lokomat Pro FreeD to protocol-defined conventional rehabilitation in the early subacute phase of first-ever ischemic stroke produced significant gains in functional ambulation category (FAC), Timed Up and Go (TUG), and Berg Balance Scale (BBS). Whether these benefits differ across clinically relevant subgroups remains unclear. We investigated potential effect modification by baseline characteristics. Methods: We performed a secondary analysis of a randomized controlled trial ( Results: The largest differential effect of RAGT was observed in patients with low baseline ambulatory capacity (FAC 0-1): 90.0% of RAGT patients versus 45.5% in the conventional group achieved ≥2-point FAC improvement at 3 months ( Conclusion: RAGT may confer greater benefit in patients with severe initial gait impairment. These exploratory findings support targeted evaluation in larger trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.